Our Mission

NASCSA's mission is to support, equip, and advocate for state controlled substances authorities, prescription monitoring program administrators, and other members in their work to advance the public's health, safety and welfare.

Visit NASCSA forum/newsgroup

Important News & Announcements

LAPPA Publishes Report on Status of State Laws for Regulating Kratom

Posted 6/2/2024

The Legislative Analysis and Public Policy Association (LAPPA) has released an updated 50-state summaries report on kratom, an herbal substance that can produce opioid- and stimulant-like effects. The report, Kratom: Summary of State Laws, includes the statutory or regulatory citation(s)...
Read More

DEA?s Annual Threat Assessment Spotlights Electronic Prescribing Fraud and Use of Counterfeit Pills

Posted 6/2/2024

DEA published its 2024 National Drug Threat Assessment that examined the trends in deaths from certain drugs, the number of seizures documented, and more. The assessment also noted that between 2021 and 2023, DEA found an increasing number of fraudulent electronic prescriptions (e-scrip...
Read More

Notice of Proposed Rulemaking (NPRM): Proposed Rescheduling of Marijuana

Posted 5/18/2024

Proposed Rescheduling of Marijuana

Below are links available through the DEA website regarding various documents associated with the proposed rescheduling action. Included is the HHS recommendation dated August 29, 2023, prior DEA denials for rescheduling, and a question-and-answer...
Read More

Latest Webinar Posted "Everything You Always Wanted to Know About Electronic Prescribing But Were Afraid to Ask"

Posted 5/7/2024

Check out our latest Youtube Upload - "Everything You Always Wanted to Know About Electronic Prescribing But Were Afraid to Ask" featuring 
Ken Whittemore, Vice President, Pharmacy & Regulatory Affairs, Surescripts and Ben Jensen, Manager of Fraud and Crisis Management, Surescri...
Read More

Don't Forget to Apply for NASCSA travel scholarships

Posted 5/6/2024

Regular members are reminded that the deadline to apply for travel scholarships to attend this year's conference that will take place October 28-31, 2024 at the Hyatt Regency in Greenville, South Carolina is June 14, 2024.  More information can be found at Read More

All news & announcements

Sponsor Spotlight

COMPASS Pathways


COMPASS Pathways is delighted to be a sponsor of NASCSA and looks forward to both engaging with controlled substances authorities, NASCSA leadership, and members to learn about their important work, and educate about our company's mission and the innovations underway using novel therapies.

COMPASS Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments.

We are developing innovative therapies and, when appropriate, combining them with psychological support and next-generation digital tools to forge new, sustainable mental health care pathways.

Our investigational COMP360 psilocybin therapy is currently undergoing phase 3 investigation in treatment-resistant depression. We are also assessing COMP360 in anorexia nervosa and post-traumatic stress disorder, across multiple clinical studies.

Learn more https://www.compasspathways.com

All Sponsors

State Controlled Substance and PMP Database

Click on a state to access the controlled substance and PMP database. Available information includes PMP and controlled substance contact information as well as PMP profiles. The database contains the most current information that is available to us. For the District of Columbia, Guam, and Puerto Rico, please use the button on the left for the inclusive drop down list.

Please use this form to contact Kam Gandhi

* Please do not submit patient health information (PHI).